Recent Patents on Drug Delivery & Formulation
Title: Patent Selections
Volume: 3 Issue: 1
Author(s): Bentham Science Publishers
Affiliation:
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Patent Selections, Recent Patents on Drug Delivery & Formulation 2009; 3 (1) . https://dx.doi.org/10.2174/187221109787158292
DOI https://dx.doi.org/10.2174/187221109787158292 |
Print ISSN 1872-2113 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4039 |
Article Metrics
Related Articles
-
Ultrasound and Microbubble Guided Drug Delivery: Mechanistic Understanding and Clinical Implications
Current Pharmaceutical Biotechnology An Overview on Chemistry and Biological Importance of Pyrrolidinone
Current Organic Synthesis A Mechanistic Overview on Male Infertility and Germ Cell Cancers
Current Pharmaceutical Design Development of Standardized <i>Cyanthillium cinereum</i> (L.) H.Rob. Extract and Determination of its Biological Activities
The Natural Products Journal Implication of Rho GTPases in Neurodegenerative Diseases
Current Drug Targets Evaluation of Antidiabetic Activity of <i>Rosmarinus officinalis var. prostratus</i> Growing in Syria in Alloxan Diabetic Rats
Current Bioactive Compounds Historical Spice as a Future Drug: Therapeutic Potential of Piperlongumine
Current Pharmaceutical Design Phosphodiesterase-5 Inhibitors: Future Perspectives
Current Pharmaceutical Design Advanced Microfluorescence Methods in Monitoring Intracellular Uptake of “Antisense” Oligonucleotides
Current Organic Chemistry Biological Role of Formaldehyde, and Cycles Related to Methylation, Demethylation, and Formaldehyde Production
Mini-Reviews in Medicinal Chemistry Bladder Cancer: A Simple Model Becomes Complex
Current Genomics Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions
Recent Patents on CNS Drug Discovery (Discontinued) CXCR4-CXCL12-Dependent Inflammatory Network and Endothelial Progenitors
Current Medicinal Chemistry The Molecular Mechanism of MAPK / ERK Inactivation
Current Genomics An Experimental Model for Exudative Age-related Macular Degeneration with Choroidal Neovascularization Using the Common Marmoset
Current Neurovascular Research Neural Progenitors and HIV-1- Associated Central Nervous System Disease in Adults and Children
Current HIV Research The Potential and Limitations of p38MAPK as a Drug Target for the Treatment of Hematological Malignancies
Current Drug Targets Subject Index to Volume 10
Current Pharmaceutical Design Crosstalk Between the Autophagy-Lysosome Pathway and the Ubiquitin-Proteasome Pathway in Retinal Pigment Epithelial Cells
Current Molecular Medicine